pneumonia
common
potenti
seriou
infecti
diseas
morbid
mortal
rate
continu
high
spite
major
advanc
steadi
progress
diagnosi
treatment
econom
impact
diseas
also
great
therefor
necessari
enlist
public
primari
care
emerg
physician
public
polici
administr
join
forc
treat
prevent
pneumonia
common
good
annual
incid
pneumonia
popul
age
year
inhabit
mortal
rate
per
inhabit
associ
cost
million
annual
respira
foundat
spanish
societi
pulmonolog
thorac
surgeri
separ
declar
pneumonia
awar
year
aim
coordin
effort
rais
awar
distribut
inform
foster
debat
la
es
una
enfermedad
infecciosa
frecuent
potencialment
grave
con
una
elevada
morbimortalidad
pesar
de
lo
continuo
relevant
avanc
con
gran
impacto
por
lo
que
es
necesario
incidir
en
la
lo
de
primaria
lo
de
urgencia
la
administracion
con
el
fin
de
intentar
unir
esfuerzo
para
tratarla
prevenirla
de
manera
convenient
con
una
incidencia
en
de
habitant
se
asocia
con
una
tasa
de
mortalidad
de
por
habitant
un
cost
anual
de
alrededor
de
millon
de
euro
la
respira
la
sociedad
de
separ
declararon
el
como
de
la
con
la
finalidad
de
elaborar
una
estrategia
conjunta
de
actividad
dirigida
facilitar
el
conocimiento
la
el
debat
en
torno
esta
enfermedad
palabra
clave
adquirida
en
la
comunidad
streptococcu
pneumonia
resistencia
de
la
pneumologist
long
call
greater
attent
pneumonia
common
potenti
seriou
diseas
high
rate
morbid
mortal
spite
import
steadi
progress
diagnosi
treatment
hospit
outpati
medic
cost
consider
spain
therefor
necessari
mobil
public
primari
care
emerg
physician
public
health
administr
join
forc
treat
prevent
pneumonia
common
good
real
incid
communityacquir
pneumonia
cap
quit
difficult
assess
avail
epidemiolog
data
come
studi
limit
patient
diagnos
treat
hospit
provid
inform
case
primari
care
level
annual
incid
rate
european
countri
believ
inhabit
differ
countri
countri
precis
data
avail
finland
annual
incid
adult
unit
kingdom
rate
adult
two
spanish
populationbas
studi
individu
year
age
estim
incid
inhabit
younger
older
group
suffer
higher
annual
rate
inhabit
age
bracket
adult
age
year
children
year
world
health
organ
figur
show
million
death
million
attribut
pneumonia
million
tuberculosi
million
chronic
obstruct
pulmonari
diseas
copd
million
lung
cancer
expect
result
respiratori
diseas
cap
main
caus
death
infecti
diseas
rank
sixth
place
overal
account
inhabit
everi
year
estim
rate
caprel
mortal
european
countri
found
great
differ
indic
uneven
data
registr
spain
respiratori
diseas
gener
greatest
morbid
mortal
cardiovascular
diseas
cancer
among
diseas
rank
main
caus
death
alzheim
diseas
pneumonia
associ
statist
signific
increas
adjust
mortal
rate
period
spain
men
women
die
pneumonia
give
mortal
rate
death
per
inhabit
accord
figur
publish
decemb
nation
statist
institut
mortal
rate
per
inhabit
put
pneumonia
ninth
place
among
caus
death
countri
rate
vari
autonom
commun
per
inhabit
catalonia
per
inhabit
aragon
caprel
mortal
determin
sever
factor
manner
clinic
present
etiolog
patient
characterist
mortal
rate
rang
hospit
need
hospit
patient
rate
rise
still
higher
around
patient
need
intens
care
unit
icu
admiss
mechan
ventil
indic
econom
impact
pneumonia
great
health
care
resourc
consum
relat
cost
gener
directli
drug
medic
visit
hospit
admiss
indirectli
day
lost
work
school
unit
state
america
million
episod
million
hospit
admiss
everi
year
annual
expenditur
us
milion
mean
cost
cap
case
treat
hospit
outpati
larg
part
direct
cost
treatment
therefor
gener
hospit
spain
mong
colleagu
observ
mean
annual
rate
hospit
case
per
inhabit
per
year
figur
increas
age
bracket
year
inhabit
per
year
although
author
also
saw
great
differ
one
spanish
autonom
commun
anoth
thu
annual
rate
rang
catalonia
inhabit
canari
island
patient
admit
everi
year
gener
spend
around
million
annual
even
exclud
admiss
inappropri
cost
hospit
cap
would
still
rang
million
annual
anoth
recent
studi
calcul
direct
cost
gener
patient
admit
cap
hospit
wherea
averag
cost
outpati
treatment
situat
pneumonia
archivo
de
contrast
respiratori
diseas
copd
numer
drug
studi
appear
articl
pneumonia
drug
therapi
found
search
journal
publish
pertain
specif
situat
circumst
thu
studi
et
al
analyz
cost
inappropri
admiss
pneumonia
undertaken
differ
cost
gener
hospit
outpati
care
moment
time
ration
use
avail
servic
cost
cut
rule
anoth
studi
colleagu
show
durat
intraven
antibiot
therapi
cap
effect
mean
length
hospit
stay
cost
treatment
add
appar
benefit
select
group
patient
recent
year
seen
develop
campaign
dissemin
health
inform
import
interest
project
spanish
lung
respira
foundat
focu
respiratori
diseas
present
import
health
care
problem
incid
cost
commun
focu
attent
copd
asthma
yearlong
attent
singl
issu
main
purpos
rais
awar
problem
among
gener
public
public
health
author
well
among
physician
context
respira
foundat
separ
ask
spanish
ministri
health
consum
affair
declar
pneumonia
awar
year
board
director
separ
creat
pneumonia
awar
committe
plan
activ
spread
inform
encourag
discuss
diseas
princip
aim
pneumonia
awar
year
rais
gener
public
awar
cap
distribut
inform
treat
prevent
b
alert
health
care
profession
differ
level
specialist
primari
care
physician
clinic
therapeut
problem
diseas
creat
emphas
role
pneumologist
treatment
research
c
call
attent
public
spokesperson
politician
social
comment
epidemiolog
import
pneumonia
rais
awar
public
health
care
polici
administr
institut
regard
import
pneumonia
commun
appropri
action
taken
especi
prevent
one
particularli
target
last
goal
develop
compar
criteria
pneumococcu
influenza
viru
vaccin
differ
spanish
autonom
commun
view
assur
resourc
opportun
geograph
balanc
pneumonia
awar
campaign
launch
barcelona
press
confer
brought
togeth
journalist
news
agenc
specialist
press
radio
televis
digit
news
media
announc
receiv
consider
media
attent
later
year
inform
plan
activ
sent
member
separ
associ
public
nation
local
press
confer
held
barcelona
madrid
valencia
bilbao
sevil
public
event
wide
messag
convey
separ
name
pneumonia
awar
year
follow
reason
pneumonia
common
potenti
seriou
diseas
consist
lung
infect
sever
inflamm
mani
microorganismsvirus
bacteria
fungican
caus
pneumonia
caus
remain
unknown
case
spite
progress
investig
diseas
overal
mortal
rate
hold
steadi
around
real
incid
pneumonia
spain
rang
case
everi
inhabit
figur
rise
case
per
inhabit
popul
year
age
pneumonia
also
one
princip
caus
infant
death
million
children
die
pneumonia
everi
year
develop
countri
smoke
alcohol
risk
factor
predispos
individu
pneumonia
import
see
doctor
first
appear
symptom
cough
fever
chill
chest
pain
short
breath
annual
vaccin
influenza
viru
pneumococcu
main
prevent
measur
antibiot
essenti
therapeut
arsen
fight
pneumonia
never
use
carelessli
without
medic
prescript
improp
use
lead
develop
resist
strain
content
campaign
pneumonia
reflect
booklet
titl
pleno
liter
full
lung
also
spanish
express
relat
call
news
loud
clear
follow
activ
list
inform
campaign
target
gener
popul
b
scientif
studi
pneumonia
promot
c
profession
develop
cours
updat
knowledg
pneumonia
telephon
survey
ascertain
gener
public
level
knowledg
diseas
e
campaign
promot
vaccin
highrisk
group
final
f
prepar
consensu
paper
discuss
proper
treatment
pneumonia
web
page
creat
make
key
inform
avail
public
form
comprehens
easi
understand
guid
diseas
physician
also
offer
complet
bibliographi
profession
literatur
diseas
space
articl
gener
press
pneumonia
also
provid
well
space
convey
inform
journalist
site
creat
way
regularli
post
updat
inform
plan
activ
throughout
campaign
year
give
particip
ambiti
project
space
one
key
activ
carri
survey
comput
assist
telephon
interview
technolog
use
variou
popul
group
target
purpos
ascertain
level
knowledg
pneumonia
among
spaniard
attitud
regard
prevent
treatment
rate
vaccin
pneumococcu
influenza
viru
determin
age
bracket
sex
urban
rural
resid
geograph
area
item
ask
measur
interviewe
would
take
case
pneumonia
preliminari
result
present
press
confer
april
final
paper
still
pend
public
singl
survey
found
among
public
archivo
de
sinc
aim
studi
publish
determin
situat
domiciliari
mechan
ventil
spain
target
popul
health
care
profession
howev
rather
gener
public
meet
object
awar
year
cours
pneumonia
develop
accredit
spanish
commiss
continu
profession
develop
physician
seaformec
cours
given
print
read
matter
inform
post
onlin
onlin
tutor
specialist
avail
spanish
autonom
commun
total
physician
enrol
cours
target
primari
care
physician
wish
updat
knowledg
cap
treatment
prevent
physician
direct
contact
commun
first
step
health
care
system
act
within
framework
public
health
care
system
type
caregiverspneumologist
primari
care
physiciansmust
coordin
readi
share
respons
cooper
essenti
given
high
preval
respiratori
diseas
treat
primari
care
set
campaign
promot
vaccin
influenza
pneumonia
among
group
risk
initi
autumn
must
also
rememb
import
aspect
correct
treatment
pneumonia
name
seriou
problem
antibiot
resist
spain
rate
resist
streptococcu
pneumonia
main
caus
cap
among
highest
world
resist
affect
treatment
option
must
understand
clinic
context
one
multicent
studi
carri
member
assembl
tuberculosi
respiratori
infect
tir
separ
object
studi
epidemiolog
clinic
manifest
cap
pneumonia
strain
resist
antibiot
rate
resist
penicillin
erythromycin
thirdgener
cephalosporin
levofloxacin
although
figur
penicillin
resist
appear
stabil
time
final
within
framework
year
dedic
awar
pneumonia
cap
studi
group
tir
assembl
brought
togeth
substanti
number
pneumologist
aim
reach
consensu
main
diagnost
process
therapeut
regimen
diseas
given
need
creat
consist
procedur
correct
current
differ
spanish
autonom
commun
effort
group
record
separ
guidelin
cap
diagnosi
treatment
brought
earlier
guidelin
uptod
keep
current
scientif
evid
adapt
spanish
situat
regard
resourc
drug
patient
care
capabl
recommend
design
provid
practic
tool
doctor
treat
pneumonia
whatev
level
health
care
system
confin
scope
cap
immunocompet
adult
year
old
exclud
therefor
case
found
institution
patient
requir
special
consider
key
point
recommend
vaccin
given
separ
respira
foundat
favor
lower
age
applic
especi
group
risk
consensu
paper
present
formal
nation
meet
separ
valencia
publish
full
form
archivo
de
abridg
version
also
publish
tryptic
facilit
quick
consult
main
point
two
year
design
pneumonia
awar
year
ask
outcom
project
aim
summar
analyz
real
shortterm
impact
januari
june
public
archivo
de
use
advanc
search
option
separ
web
site
request
articl
word
pneumonia
titl
abstract
specifi
aforement
date
limit
relat
public
also
select
extend
search
even
pneumonia
appear
titl
abstract
articl
special
supplement
found
first
search
also
locat
exclud
articl
actual
entiti
even
word
pneumonia
present
eg
articl
concern
bronchiol
obliteran
organ
pneumonia
number
articl
directli
relat
pneumonia
publish
june
shown
tabl
distribut
articl
type
public
shown
tabl
editori
origin
articl
special
articl
review
articl
paper
separ
recommend
seri
case
report
letter
editor
set
guidelin
set
guidelin
includ
separ
work
group
recommend
diagnosi
ventilatorassoci
pneumonia
recommend
issu
separ
work
group
cooper
societi
treatment
seriou
nosocomi
pneumonia
third
give
recommend
latin
american
thorac
associ
alat
nosocomi
pneumonia
addit
articl
publish
variou
annual
supplement
relat
seminar
simpli
supplement
overview
hot
topic
pneumolog
brought
total
tabl
show
type
public
appear
year
noteworthi
number
origin
articl
publish
tabl
review
scientif
content
articl
publish
sinc
reveal
substanti
chang
time
line
investig
follow
understand
concern
first
character
pneumonia
risk
factor
etiolog
pattern
diagnost
method
treatmentin
short
studi
pneumologist
treat
diseas
spain
studi
descript
practic
set
one
studi
help
establish
base
work
must
cite
multicent
project
carri
separ
tir
assembl
group
promot
sever
studi
recent
year
claim
public
highimpact
journal
refer
nace
studi
acronym
deriv
cap
spanish
tir
project
involv
spanish
hospit
patient
main
object
determin
diagnost
therapeut
protocol
follow
relat
cap
countri
group
found
patient
requir
admiss
etiolog
diagnos
reach
case
pneumonia
identifi
common
pathogen
two
third
patient
year
old
consist
indic
cap
requir
admiss
often
older
age
bracket
comorbid
present
case
presenc
chronic
diseas
copd
risk
factor
seen
guidelin
treatment
cap
gener
follow
hospit
mortal
due
cap
percentag
patient
need
icu
admiss
number
complic
low
rang
good
practic
spanish
pneumologist
relat
diseas
confirm
spite
dispar
diagnost
treatment
criteria
older
patient
admit
cap
made
larg
percentag
sampl
life
expect
extend
need
becom
accustom
pattern
incid
cap
known
significantli
higher
popul
age
year
also
find
higher
preval
chronic
debilit
diseas
increas
risk
pneumonia
consider
pictur
also
chang
rang
etiolog
agent
respons
cap
clinic
manifest
diseas
clinic
cours
pneumonia
elderli
special
characterist
manag
way
younger
patient
review
recent
public
archivo
de
reveal
concern
deepen
understand
diseas
popul
anoth
articl
separ
tir
assembl
must
highlight
line
first
prospect
multicent
studi
cap
characterist
patient
year
old
sixteen
particip
spanish
hospit
treat
patient
mean
age
year
contrari
common
belief
cap
acut
case
pneumonia
causal
agent
case
microbiolog
diagnosi
avail
mortal
low
compar
crude
mortal
rate
observ
retrospect
studi
clement
et
al
similar
hospit
mortal
mortal
observ
et
al
risk
factor
poor
prognosi
identifi
tir
studi
follow
patient
previous
bedridden
alter
mental
statu
absenc
chill
plasma
creatinin
level
mgdl
ratio
pao
inspir
oxygen
fraction
fio
less
upon
admiss
kidney
failur
shock
pneumonia
episod
independ
risk
factor
associ
mortal
found
serum
creatinin
level
mgdl
rel
risk
rr
bedridden
patient
rr
pao
fio
rr
neoplast
diseas
rr
advanc
age
year
absenc
cough
low
blood
pressur
elev
phosphat
level
clement
et
al
found
presenc
chest
pain
associ
lower
risk
death
rr
decemb
et
al
publish
interest
studi
analyz
differ
cap
elderli
resid
geriatr
facil
comparison
patient
live
privat
home
cap
institution
geriatr
patient
consid
differ
term
etiolog
present
prognosi
spanish
studi
done
confirm
profil
howev
alsonso
made
special
mention
studi
survey
public
volum
archivo
de
cowork
prospect
analyz
cap
admit
patient
year
old
period
month
special
attent
function
statu
comorbid
ninetyon
patient
geriatr
facil
enrol
geriatr
facil
resid
older
concomit
diseas
function
impair
mortal
higher
resid
geriatr
facil
live
privat
home
although
rate
homeliv
patient
lower
report
earlier
studi
cours
prognosi
also
seen
analysi
sourc
transfer
prior
admiss
case
come
group
residenti
facil
particularli
sever
proven
major
risk
factor
death
even
etiolog
agent
differ
usual
one
first
issu
archivo
de
becam
offici
journal
commun
scientif
activ
latin
american
thorac
societi
alat
sinc
separ
alat
close
contact
contribut
alat
member
publish
steadi
rate
consist
attent
diseas
copd
alat
treatment
guidelin
publish
journal
also
publish
special
articl
present
societi
guidelin
cap
treatment
august
therebi
provid
use
updat
previou
recommend
colleagu
across
ocean
must
also
cope
problem
antibiot
resist
share
concern
pneumonia
suscept
search
appropri
antimicrobi
agent
motiv
intern
clinic
trial
evalu
efficaci
safeti
treatment
moxifloxacin
comparison
amoxicillin
patient
suspect
pneumococc
cap
studi
reflect
experi
latin
american
countri
list
germ
isol
pattern
antibiot
sensit
clinic
microbiolog
find
high
preval
pneumonia
low
suscept
penicillin
document
taken
account
establish
empir
treatment
guidelin
countri
anoth
latin
american
studi
carri
chile
look
role
bronchoalveolar
lavag
diagnosi
pneumonia
due
opportunist
germ
immunodepress
children
complic
assess
found
approach
safe
provid
suffici
diagnost
yield
allow
etiolog
diagnosi
lung
infiltr
reach
still
chile
et
al
undertook
prospect
descript
studi
clinic
present
prognost
factor
treatment
adult
admit
icu
sever
cap
patient
seri
mean
sd
age
year
concomit
diseas
belong
high
risk
categori
accord
pneumonia
sever
index
psi
etiolog
demonstr
case
pneumonia
gramneg
bacilli
mycoplasma
pneumonia
among
main
complic
observ
need
mechan
ventil
septic
shock
heart
failur
arrhythmia
mortal
rate
day
factor
associ
higher
risk
death
acut
kidney
failur
odd
ratio
blood
sugar
level
mgdl
septemb
et
al
publish
editori
analyz
factor
influenc
poor
outcom
mortal
pneumonia
start
fact
cap
may
poor
outcom
even
antibiot
therapi
cover
adequ
broad
spectrum
pathogen
sensit
author
emphas
develop
recent
year
prognost
scale
estim
likelihood
death
cap
way
appli
homogen
univers
scale
manag
focu
attent
sign
unfavor
evolut
unrel
pathogen
rather
process
within
patient
variou
paper
publish
within
line
investig
yet
anoth
project
organ
tir
assembl
cap
treatment
failur
spain
neumofail
studi
newer
approach
identifi
risk
factor
relat
respons
therapi
inform
use
detect
poor
evolut
whether
patient
risk
classif
high
low
mortal
nonetheless
clear
analyz
respons
therapi
requir
research
relationship
host
microorgan
one
hypothesi
investig
hold
imbal
host
respons
express
overproduct
proinflammatori
cytokin
tumor
necrosi
factor
tnf
interleukin
il
relat
poor
outcom
high
level
found
context
cap
correl
mortal
exagger
inflammatori
respons
develop
neg
effect
outcom
poorli
understood
although
possibl
microorgan
bacteri
load
might
trigger
increas
product
cytokin
affect
antibiot
treatment
host
suscept
well
given
cytokin
product
genet
determin
line
investig
develop
look
relat
genet
polymorph
host
respons
infect
along
cours
diseas
meanwhil
clinician
need
biolog
marker
abl
estim
therapeut
respons
well
treatment
readi
modul
current
c
reactiv
protein
procalcitonin
promis
elev
concentr
found
correl
treatment
failur
de
castro
cowork
discuss
line
research
supplement
relat
hot
topic
clear
individu
variat
suscept
infecti
diseas
differ
sever
run
cours
alway
suspect
genet
factor
must
play
role
suscept
addit
known
environment
factor
debat
underway
author
ask
much
genet
make
account
differ
way
respond
infect
independ
wellknown
factor
prior
immunolog
statu
acquir
immun
variat
virul
microorgan
human
genom
project
provid
start
point
analyz
human
genet
divers
singlenucleotid
polymorph
import
preval
type
variat
human
genom
account
genet
differ
individu
among
polymorph
implic
antigen
recognit
complement
system
protein
like
mannos
bind
lectin
mbl
pluripot
molecul
innat
immun
system
abl
activ
complement
bind
variou
sugar
surfac
microb
mbl
also
act
directli
opsonin
discuss
varieti
mbl
polymorph
author
note
true
allel
variant
associ
low
protein
titer
link
greater
suscept
cap
normal
wildtyp
genotyp
confer
greater
risk
develop
sever
form
diseas
next
phase
analysi
genet
associ
infecti
diseas
allow
us
select
candid
gene
studi
human
understand
molecular
event
must
take
place
pathogen
invad
host
well
event
requir
host
elimin
pathogen
knowledg
undoubtedli
revolution
research
develop
area
vaccin
antimicrobi
drug
june
editori
de
castro
question
pose
medic
specialist
provid
patient
better
care
two
issu
must
consid
respond
seem
one
hand
cost
health
care
cours
patient
ill
factor
clearli
influenc
first
profil
physician
give
care
seem
clear
given
type
patient
specialist
care
cost
although
also
necessari
assess
whether
care
improv
clinic
cours
among
respiratori
diseas
improv
outcom
demonstr
asthma
object
would
studi
influenc
physician
profil
use
resourc
treat
cap
prognosi
know
cap
patient
hospit
gener
higher
health
care
cost
treat
outpati
nevertheless
present
consist
criteria
decid
whether
hospit
pneumonia
patient
decid
durat
hospit
stay
guid
use
antibiot
use
differ
hospit
earlier
studi
exampl
analyz
influenc
durat
intraven
therapi
durat
hospit
stay
cost
although
possibl
differ
relat
sever
associ
risk
factor
like
medic
specialti
affect
variat
care
process
follow
treatment
chosen
therefor
outcom
patient
also
specul
differ
cap
treatment
observ
among
differ
specialist
could
reduc
structur
protocol
follow
accord
editori
author
note
scarc
differ
treatment
prescrib
pneumologist
infecti
diseas
specialist
observ
underlin
role
medic
experi
treat
diseas
specif
volum
patient
treat
cours
year
matter
natur
specif
academ
qualif
june
issu
journal
capelastegui
et
al
also
investig
whether
variat
cap
treatment
influenc
hospit
depart
took
respons
effect
clinic
cours
compar
patient
treat
depart
pneumolog
intern
medicin
infecti
diseas
mix
group
specialti
look
treatment
outcom
random
sampl
patient
drawn
among
cap
patient
admit
hospit
sever
adjust
sever
ill
patient
treat
pneumologist
hospit
mortal
rate
lower
internist
durat
intraven
treatment
significantli
shorter
latter
observ
seem
partli
explain
shorter
hospit
stay
patient
treat
pneumolog
depart
author
howev
observ
durat
intraven
antibiot
therapi
appear
add
benefit
retrospect
natur
studi
capelastegui
colleagu
lack
homogen
patient
admit
differ
depart
prevent
author
reach
definit
conclus
although
differ
mortal
rate
observ
could
attribut
differ
antimicrobi
therapypneumologist
seem
use
macrolid
internist
antibiot
therapi
consid
appropri
howev
case
depart
case
intern
medicin
depart
certain
studi
suggest
includ
macrolid
antibiot
initi
prescrib
regimen
associ
lower
mortal
author
howev
unabl
confirm
find
capelastegui
colleagu
publish
anoth
origin
articl
june
assess
evolut
qualiti
treatment
patient
admit
cap
period
year
previous
demonstr
appli
practic
guidelin
march
onward
improv
result
cap
treatment
prospect
observ
studi
author
demonstr
statist
signific
trend
follow
indic
reduc
cost
hospit
p
shorter
hospit
stay
p
shorter
durat
total
antibiot
therapi
p
increas
coverag
atyp
pathogen
p
greater
administr
antibiot
within
first
hour
p
found
signific
differ
hospit
mortal
mortal
readmiss
within
day
also
identifi
area
improv
low
percentag
admiss
intens
care
unit
inappropri
admiss
lowrisk
patient
psi
iiii
therefor
main
conclus
systemat
monitor
indic
guid
allow
understand
assess
clinic
practic
verifi
favor
evolut
mani
indic
identifi
aspect
improv
clinician
use
guidelin
systemat
monitor
indic
becom
featur
usual
clinic
practic
ongo
qualiti
assess
practic
control
variabl
possibl
anoth
area
content
review
cap
patient
also
copd
articl
et
al
publish
novemb
analyz
incid
sever
psi
class
mortal
rate
associ
pneumonia
occur
cohort
patient
diagnosi
copd
period
year
found
overal
incid
pneumonia
personyear
sever
copd
base
fev
percentag
predict
mild
patient
moder
sever
seventysix
episod
cap
nosocomi
fourteen
cap
episod
class
v
sever
class
iv
class
iii
class
ii
overal
mortal
among
nosocomi
pneumonia
rate
among
cap
case
confid
interv
assess
cap
mortal
rate
sever
class
v
mortal
class
iv
death
occur
sever
class
thu
copd
patient
high
incid
pneumonia
half
case
cap
fall
risk
class
iv
v
patient
anoth
studi
ruiz
de
et
al
observ
retrospect
copd
patient
cap
mortal
rate
durat
hospit
stay
compar
cap
patient
higher
risk
level
class
iv
v
author
found
signific
differ
percentag
patient
copd
use
home
oxygen
therapi
die
use
oxygen
use
oxygen
well
differ
risk
class
solsona
et
al
report
mortal
rate
copd
patient
requir
icu
admiss
mechan
ventil
treat
sever
cap
review
public
pneumonia
studi
diagnost
method
must
includ
thu
march
editori
molino
note
simpl
method
detect
urinari
antigen
compon
legionella
speci
pneumonia
progress
consider
brought
benefit
applic
daili
clinic
practic
clear
avail
etiolog
diagnosi
cap
contribut
fast
reliabl
prescript
direct
antibiot
therapi
word
author
would
mean
prescript
narrow
spectrum
antimicrobi
agent
avoid
combin
basi
urin
test
fact
microbi
antigen
concentr
fluid
other
lack
antibodi
affect
result
sensit
pneumonia
urinari
antigen
test
patient
bacteriemia
patient
bacterem
sensit
specif
exce
suffici
experi
consid
urinari
antigen
test
develop
use
earli
reliabl
diagnosi
pneumonia
due
legionella
speci
pneumonia
prevent
cap
anoth
knowledg
area
consid
prevent
take
form
fight
caus
pathogen
typic
action
specif
vaccin
pneumococcu
altern
involv
attempt
elimin
risk
factor
favor
develop
diseas
instanc
influenza
vaccin
antismok
campaign
escribano
montan
et
al
point
import
influenza
vaccin
pneumonia
prevent
given
influenza
viru
frequent
predispos
patient
develop
seriou
bacteri
pneumonia
alter
abil
lung
elimin
pneumonia
bacteri
load
therefor
increas
along
inflammatori
respons
pathogen
note
et
al
influenza
vaccin
reduc
need
hospit
either
influenza
pneumonia
reduc
mortal
well
separ
guidelin
cap
give
thorough
coverag
use
pneumococc
vaccin
march
rodenstein
reflect
worldwid
panic
engend
sever
acut
respiratori
syndrom
sar
editori
june
blanquer
discuss
situat
began
novemb
sever
citi
guandong
region
china
outbreak
atyp
pneumonia
whose
etiolog
unknown
first
later
attribut
coronaviru
sar
initi
infect
person
die
health
care
profession
front
line
made
patient
avian
flu
caught
attent
past
sever
month
rodenstein
wrote
come
last
origin
articl
publish
period
review
studi
noninvas
diagnosi
pulmonari
inflamm
appear
march
divers
approach
use
achiev
complex
goal
level
efficaci
safeti
vari
great
deal
normal
lung
balanc
oxid
antioxid
abl
maintain
fluid
line
airway
fill
extracellular
space
highli
reduc
state
increas
concentr
oxid
decreas
overus
antioxid
lead
imbal
result
oxid
stress
phenomenon
form
part
essenti
chain
event
result
state
airway
inflamm
bacteri
infect
collect
freez
exhal
breath
condens
ebc
techniqu
sampl
fluid
coat
airway
analysi
substanc
becom
dissolv
air
pass
ebc
analysi
subject
certain
amount
debat
great
variabl
result
scarciti
systemat
studi
techniqu
romero
et
al
ask
whether
ebc
analysi
could
reflect
oxid
stress
intrins
pulmonari
inflamm
context
sever
pulmonari
infect
oxid
becom
abund
author
studi
patient
group
subject
without
respiratori
diseas
patient
multilobar
pneumonia
variou
etiolog
copd
sever
pneumonia
necessit
mechan
ventil
ebc
sampl
taken
within
hour
admiss
analyz
nitrit
nitrat
myeloperoxidas
mpo
signific
differ
detect
control
group
patient
differ
patient
group
author
therefor
conclud
ebc
analysi
mpo
could
provid
indic
oxid
stress
airway
patient
lung
infect
approxim
year
half
pass
sinc
pneumonia
awar
year
project
left
us
import
scientif
contribut
object
ambiti
project
scope
come
end
one
alway
left
feel
could
accomplish
someth
could
done
better
end
awar
singl
year
littl
time
discuss
diseasewheth
copd
asthma
pneumonia
sleep
disord
cancerbut
hope
contribut
further
knowledg
measur
improv
treatment
pneumonia
spain
awar
must
defend
specialti
broaden
horizon
clinic
research
play
increasingli
import
role
pneumolog
commit
commun
oblig
us
move
new
area
face
new
challeng
involv
care
critic
ill
respiratori
patient
promot
creation
intermedi
respiratori
care
unit
pneumologist
manag
sever
pneumonia
must
rememb
respiratori
infect
loom
import
respiratori
infect
rare
spain
yet
recent
year
seen
travel
exot
destin
immigr
increas
appreci
trend
suppos
new
challeng
danger
fact
contact
enter
differenti
diagnosi
pneumonia
end
respira
foundat
separ
scientif
associ
work
within
framework
societi
creat
associ
therefor
aim
increas
scientif
knowledg
promot
better
health
habit
commun
serv
modern
develop
societi
like
health
campaign
base
make
appropri
accur
adequ
inform
avail
public
